Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus

Author:

Hussain ArifORCID,Via Gabriele,Melniker Lawrence,Goffi Alberto,Tavazzi Guido,Neri Luca,Villen Tomas,Hoppmann Richard,Mojoli Francesco,Noble Vicki,Zieleskiewicz Laurent,Blanco Pablo,Ma Irene W. Y.,Wahab Mahathar Abd.,Alsaawi Abdulmohsen,Al Salamah Majid,Balik Martin,Barca Diego,Bendjelid Karim,Bouhemad Belaid,Bravo-Figueroa Pablo,Breitkreutz Raoul,Calderon Juan,Connolly Jim,Copetti Roberto,Corradi Francesco,Dean Anthony J.,Denault André,Govil Deepak,Graci Carmela,Ha Young-Rock,Hurtado Laura,Kameda Toru,Lanspa Michael,Laursen Christian B.,Lee Francis,Liu Rachel,Meineri Massimiliano,Montorfano Miguel,Nazerian Peiman,Nelson Bret P.,Neskovic Aleksandar N.,Nogue Ramon,Osman Adi,Pazeli José,Pereira-Junior Elmo,Petrovic Tomislav,Pivetta Emanuele,Poelaert Jan,Price Susanna,Prosen Gregor,Rodriguez Shalim,Rola Philippe,Royse Colin,Chen Yale Tung,Wells Mike,Wong Adrian,Xiaoting Wang,Zhen Wang,Arabi Yaseen

Abstract

AbstractCOVID-19 has caused great devastation in the past year. Multi-organ point-of-care ultrasound (PoCUS) including lung ultrasound (LUS) and focused cardiac ultrasound (FoCUS) as a clinical adjunct has played a significant role in triaging, diagnosis and medical management of COVID-19 patients. The expert panel from 27 countries and 6 continents with considerable experience of direct application of PoCUS on COVID-19 patients presents evidence-based consensus using GRADE methodology for the quality of evidence and an expedited, modified-Delphi process for the strength of expert consensus. The use of ultrasound is suggested in many clinical situations related to respiratory, cardiovascular and thromboembolic aspects of COVID-19, comparing well with other imaging modalities. The limitations due to insufficient data are highlighted as opportunities for future research.

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Reference160 articles.

1. Coronavirus disease 2019 (COVID-19) Situation Report – 92 [https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200801-covid-19-sitrep-194.pdf?sfvrsn=401287f3_2]

2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020.

3. Mojoli F, Mongodi S, Orlando A, Arisi E, Pozzi M, Civardi L, Tavazzi G, Baldanti F, Bruno R, Iotti GA, et al. Our recommendations for acute management of COVID-19. Crit Care. 2020;24(1):207.

4. Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med 2020.

5. Clinical management of severe acute respiratory infection when COVID-19 is suspected - Interim guidance. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3